Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Female Urinary Incontinence Treatment Device Market Research Report 2025

Global Female Urinary Incontinence Treatment Device Market Research Report 2025

Industry: Medical Devices & Consumables

Published Date: 2025-01-16

Pages: 94 Pages

Report ld: 3444471

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Female Urinary Incontinence Treatment Device Market Size(US$)

CAGR 2025-2031

Market Size,2031

USD 1,696

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,130 million

Market Forecast in 2031(Value)

US$ 1,696 million

CAGR

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Female Urinary Incontinence Treatment Device was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1696 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Female Urinary Incontinence Treatment Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Urinary Incontinence Treatment Device.

The Female Urinary Incontinence Treatment Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Female Urinary Incontinence Treatment Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Urinary Incontinence Treatment Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Karl Storz

Johnson and Johnson

Coloplast

Boston Scientific

Teleflex

Medtronic

InControl Medical

Atlantic Therapeutics Group

Axonics Modulation Technologies

Laborie

Micron Medical

American Medical Solutions

Segment by Type

Urethral Devices

Internal Vaginal Devices

Segment by Application

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Female Urinary Incontinence Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Female Urinary Incontinence Treatment Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Female Urinary Incontinence Treatment Device Market Overview

1.1 Product Definition

1.2 Female Urinary Incontinence Treatment Device by Type

1.2.1 Global Female Urinary Incontinence Treatment Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Urethral Devices

1.2.3 Internal Vaginal Devices

1.3 Female Urinary Incontinence Treatment Device by Application

1.3.1 Global Female Urinary Incontinence Treatment Device Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Ambulatory Surgical Centers

1.3.5 Others

1.4 Global Female Urinary Incontinence Treatment Device Market Size Estimates and Forecasts

1.4.1 Global Female Urinary Incontinence Treatment Device Revenue 2020-2031

1.4.2 Global Female Urinary Incontinence Treatment Device Sales 2020-2031

1.4.3 Global Female Urinary Incontinence Treatment Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Female Urinary Incontinence Treatment Device Market Competition by Manufacturers

2.1 Global Female Urinary Incontinence Treatment Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Female Urinary Incontinence Treatment Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Female Urinary Incontinence Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Product Type & Application

2.7 Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Date of Enter into This Industry

2.8 Global Female Urinary Incontinence Treatment Device Market Competitive Situation and Trends

2.8.1 Global Female Urinary Incontinence Treatment Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Female Urinary Incontinence Treatment Device Players Market Share by Revenue

2.8.3 Global Female Urinary Incontinence Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Female Urinary Incontinence Treatment Device Market Scenario by Region

3.1 Global Female Urinary Incontinence Treatment Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Female Urinary Incontinence Treatment Device Sales by Region: 2020-2031

3.2.1 Global Female Urinary Incontinence Treatment Device Sales by Region: 2020-2025

3.2.2 Global Female Urinary Incontinence Treatment Device Sales by Region: 2026-2031

3.3 Global Female Urinary Incontinence Treatment Device Revenue by Region: 2020-2031

3.3.1 Global Female Urinary Incontinence Treatment Device Revenue by Region: 2020-2025

3.3.2 Global Female Urinary Incontinence Treatment Device Revenue by Region: 2026-2031

3.4 North America Female Urinary Incontinence Treatment Device Market Facts & Figures by Country

3.4.1 North America Female Urinary Incontinence Treatment Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Female Urinary Incontinence Treatment Device Sales by Country (2020-2031)

3.4.3 North America Female Urinary Incontinence Treatment Device Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Female Urinary Incontinence Treatment Device Market Facts & Figures by Country

3.5.1 Europe Female Urinary Incontinence Treatment Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Female Urinary Incontinence Treatment Device Sales by Country (2020-2031)

3.5.3 Europe Female Urinary Incontinence Treatment Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Female Urinary Incontinence Treatment Device Market Facts & Figures by Region

3.6.1 Asia Pacific Female Urinary Incontinence Treatment Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Female Urinary Incontinence Treatment Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Female Urinary Incontinence Treatment Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Female Urinary Incontinence Treatment Device Market Facts & Figures by Country

3.7.1 Latin America Female Urinary Incontinence Treatment Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Female Urinary Incontinence Treatment Device Sales by Country (2020-2031)

3.7.3 Latin America Female Urinary Incontinence Treatment Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Female Urinary Incontinence Treatment Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Female Urinary Incontinence Treatment Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Female Urinary Incontinence Treatment Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Female Urinary Incontinence Treatment Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Female Urinary Incontinence Treatment Device Sales by Type (2020-2031)

4.1.1 Global Female Urinary Incontinence Treatment Device Sales by Type (2020-2025)

4.1.2 Global Female Urinary Incontinence Treatment Device Sales by Type (2026-2031)

4.1.3 Global Female Urinary Incontinence Treatment Device Sales Market Share by Type (2020-2031)

4.2 Global Female Urinary Incontinence Treatment Device Revenue by Type (2020-2031)

4.2.1 Global Female Urinary Incontinence Treatment Device Revenue by Type (2020-2025)

4.2.2 Global Female Urinary Incontinence Treatment Device Revenue by Type (2026-2031)

4.2.3 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Type (2020-2031)

4.3 Global Female Urinary Incontinence Treatment Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Female Urinary Incontinence Treatment Device Sales by Application (2020-2031)

5.1.1 Global Female Urinary Incontinence Treatment Device Sales by Application (2020-2025)

5.1.2 Global Female Urinary Incontinence Treatment Device Sales by Application (2026-2031)

5.1.3 Global Female Urinary Incontinence Treatment Device Sales Market Share by Application (2020-2031)

5.2 Global Female Urinary Incontinence Treatment Device Revenue by Application (2020-2031)

5.2.1 Global Female Urinary Incontinence Treatment Device Revenue by Application (2020-2025)

5.2.2 Global Female Urinary Incontinence Treatment Device Revenue by Application (2026-2031)

5.2.3 Global Female Urinary Incontinence Treatment Device Revenue Market Share by Application (2020-2031)

5.3 Global Female Urinary Incontinence Treatment Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 BD

6.1.1 BD Company Information

6.1.2 BD Description and Business Overview

6.1.3 BD Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 BD Female Urinary Incontinence Treatment Device Product Portfolio

6.1.5 BD Recent Developments/Updates

6.2 Karl Storz

6.2.1 Karl Storz Company Information

6.2.2 Karl Storz Description and Business Overview

6.2.3 Karl Storz Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Karl Storz Female Urinary Incontinence Treatment Device Product Portfolio

6.2.5 Karl Storz Recent Developments/Updates

6.3 Johnson and Johnson

6.3.1 Johnson and Johnson Company Information

6.3.2 Johnson and Johnson Description and Business Overview

6.3.3 Johnson and Johnson Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Johnson and Johnson Female Urinary Incontinence Treatment Device Product Portfolio

6.3.5 Johnson and Johnson Recent Developments/Updates

6.4 Coloplast

6.4.1 Coloplast Company Information

6.4.2 Coloplast Description and Business Overview

6.4.3 Coloplast Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Coloplast Female Urinary Incontinence Treatment Device Product Portfolio

6.4.5 Coloplast Recent Developments/Updates

6.5 Boston Scientific

6.5.1 Boston Scientific Company Information

6.5.2 Boston Scientific Description and Business Overview

6.5.3 Boston Scientific Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Boston Scientific Female Urinary Incontinence Treatment Device Product Portfolio

6.5.5 Boston Scientific Recent Developments/Updates

6.6 Teleflex

6.6.1 Teleflex Company Information

6.6.2 Teleflex Description and Business Overview

6.6.3 Teleflex Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Teleflex Female Urinary Incontinence Treatment Device Product Portfolio

6.6.5 Teleflex Recent Developments/Updates

6.7 Medtronic

6.7.1 Medtronic Company Information

6.7.2 Medtronic Description and Business Overview

6.7.3 Medtronic Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Medtronic Female Urinary Incontinence Treatment Device Product Portfolio

6.7.5 Medtronic Recent Developments/Updates

6.8 InControl Medical

6.8.1 InControl Medical Company Information

6.8.2 InControl Medical Description and Business Overview

6.8.3 InControl Medical Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 InControl Medical Female Urinary Incontinence Treatment Device Product Portfolio

6.8.5 InControl Medical Recent Developments/Updates

6.9 Atlantic Therapeutics Group

6.9.1 Atlantic Therapeutics Group Company Information

6.9.2 Atlantic Therapeutics Group Description and Business Overview

6.9.3 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Product Portfolio

6.9.5 Atlantic Therapeutics Group Recent Developments/Updates

6.10 Axonics Modulation Technologies

6.10.1 Axonics Modulation Technologies Company Information

6.10.2 Axonics Modulation Technologies Description and Business Overview

6.10.3 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Product Portfolio

6.10.5 Axonics Modulation Technologies Recent Developments/Updates

6.11 Laborie

6.11.1 Laborie Company Information

6.11.2 Laborie Description and Business Overview

6.11.3 Laborie Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Laborie Female Urinary Incontinence Treatment Device Product Portfolio

6.11.5 Laborie Recent Developments/Updates

6.12 Micron Medical

6.12.1 Micron Medical Company Information

6.12.2 Micron Medical Description and Business Overview

6.12.3 Micron Medical Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Micron Medical Female Urinary Incontinence Treatment Device Product Portfolio

6.12.5 Micron Medical Recent Developments/Updates

6.13 American Medical Solutions

6.13.1 American Medical Solutions Company Information

6.13.2 American Medical Solutions Description and Business Overview

6.13.3 American Medical Solutions Female Urinary Incontinence Treatment Device Sales, Revenue and Gross Margin (2020-2025)

6.13.4 American Medical Solutions Female Urinary Incontinence Treatment Device Product Portfolio

6.13.5 American Medical Solutions Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Female Urinary Incontinence Treatment Device Industry Chain Analysis

7.2 Female Urinary Incontinence Treatment Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Female Urinary Incontinence Treatment Device Production Mode & Process Analysis

7.4 Female Urinary Incontinence Treatment Device Sales and Marketing

7.4.1 Female Urinary Incontinence Treatment Device Sales Channels

7.4.2 Female Urinary Incontinence Treatment Device Distributors

7.5 Female Urinary Incontinence Treatment Device Customer Analysis

8 Female Urinary Incontinence Treatment Device Market Dynamics

8.1 Female Urinary Incontinence Treatment Device Industry Trends

8.2 Female Urinary Incontinence Treatment Device Market Drivers

8.3 Female Urinary Incontinence Treatment Device Market Challenges

8.4 Female Urinary Incontinence Treatment Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Female Urinary Incontinence Treatment Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Female Urinary Incontinence Treatment Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Female Urinary Incontinence Treatment Device Market Competitive Situation by Manufacturers in 2024

Table 4. Global Female Urinary Incontinence Treatment Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Female Urinary Incontinence Treatment Device Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Female Urinary Incontinence Treatment Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Female Urinary Incontinence Treatment Device Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Female Urinary Incontinence Treatment Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Female Urinary Incontinence Treatment Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Product Type & Application

Table 12. Global Key Manufacturers of Female Urinary Incontinence Treatment Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Female Urinary Incontinence Treatment Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Urinary Incontinence Treatment Device as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Female Urinary Incontinence Treatment Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Female Urinary Incontinence Treatment Device Sales by Region (2020-2025) & (K Units)

Table 18. Global Female Urinary Incontinence Treatment Device Sales Market Share by Region (2020-2025)

Table 19. Global Female Urinary Incontinence Treatment Device Sales by Region (2026-2031) & (K Units)

Table 20. Global Female Urinary Incontinence Treatment Device Sales Market Share by Region (2026-2031)

Table 21. Global Female Urinary Incontinence Treatment Device Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Region (2020-2025)

Table 23. Global Female Urinary Incontinence Treatment Device Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Region (2026-2031)

Table 25. North America Female Urinary Incontinence Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Female Urinary Incontinence Treatment Device Sales by Country (2020-2025) & (K Units)

Table 27. North America Female Urinary Incontinence Treatment Device Sales by Country (2026-2031) & (K Units)

Table 28. North America Female Urinary Incontinence Treatment Device Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Female Urinary Incontinence Treatment Device Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Female Urinary Incontinence Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Female Urinary Incontinence Treatment Device Sales by Country (2020-2025) & (K Units)

Table 32. Europe Female Urinary Incontinence Treatment Device Sales by Country (2026-2031) & (K Units)

Table 33. Europe Female Urinary Incontinence Treatment Device Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Female Urinary Incontinence Treatment Device Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Female Urinary Incontinence Treatment Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Female Urinary Incontinence Treatment Device Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Female Urinary Incontinence Treatment Device Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Female Urinary Incontinence Treatment Device Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Female Urinary Incontinence Treatment Device Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Female Urinary Incontinence Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Female Urinary Incontinence Treatment Device Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Female Urinary Incontinence Treatment Device Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Female Urinary Incontinence Treatment Device Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Female Urinary Incontinence Treatment Device Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Female Urinary Incontinence Treatment Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Female Urinary Incontinence Treatment Device Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Female Urinary Incontinence Treatment Device Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Female Urinary Incontinence Treatment Device Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Female Urinary Incontinence Treatment Device Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Female Urinary Incontinence Treatment Device Sales (K Units) by Type (2020-2025)

Table 51. Global Female Urinary Incontinence Treatment Device Sales (K Units) by Type (2026-2031)

Table 52. Global Female Urinary Incontinence Treatment Device Sales Market Share by Type (2020-2025)

Table 53. Global Female Urinary Incontinence Treatment Device Sales Market Share by Type (2026-2031)

Table 54. Global Female Urinary Incontinence Treatment Device Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Female Urinary Incontinence Treatment Device Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Type (2020-2025)

Table 57. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Type (2026-2031)

Table 58. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Type (2020-2025)

Table 59. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Type (2026-2031)

Table 60. Global Female Urinary Incontinence Treatment Device Sales (K Units) by Application (2020-2025)

Table 61. Global Female Urinary Incontinence Treatment Device Sales (K Units) by Application (2026-2031)

Table 62. Global Female Urinary Incontinence Treatment Device Sales Market Share by Application (2020-2025)

Table 63. Global Female Urinary Incontinence Treatment Device Sales Market Share by Application (2026-2031)

Table 64. Global Female Urinary Incontinence Treatment Device Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Female Urinary Incontinence Treatment Device Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Application (2020-2025)

Table 67. Global Female Urinary Incontinence Treatment Device Revenue Market Share by Application (2026-2031)

Table 68. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Application (2020-2025)

Table 69. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Application (2026-2031)

Table 70. BD Company Information

Table 71. BD Description and Business Overview

Table 72. BD Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. BD Female Urinary Incontinence Treatment Device Product

Table 74. BD Recent Developments/Updates

Table 75. Karl Storz Company Information

Table 76. Karl Storz Description and Business Overview

Table 77. Karl Storz Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Karl Storz Female Urinary Incontinence Treatment Device Product

Table 79. Karl Storz Recent Developments/Updates

Table 80. Johnson and Johnson Company Information

Table 81. Johnson and Johnson Description and Business Overview

Table 82. Johnson and Johnson Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Johnson and Johnson Female Urinary Incontinence Treatment Device Product

Table 84. Johnson and Johnson Recent Developments/Updates

Table 85. Coloplast Company Information

Table 86. Coloplast Description and Business Overview

Table 87. Coloplast Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Coloplast Female Urinary Incontinence Treatment Device Product

Table 89. Coloplast Recent Developments/Updates

Table 90. Boston Scientific Company Information

Table 91. Boston Scientific Description and Business Overview

Table 92. Boston Scientific Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Boston Scientific Female Urinary Incontinence Treatment Device Product

Table 94. Boston Scientific Recent Developments/Updates

Table 95. Teleflex Company Information

Table 96. Teleflex Description and Business Overview

Table 97. Teleflex Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Teleflex Female Urinary Incontinence Treatment Device Product

Table 99. Teleflex Recent Developments/Updates

Table 100. Medtronic Company Information

Table 101. Medtronic Description and Business Overview

Table 102. Medtronic Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Medtronic Female Urinary Incontinence Treatment Device Product

Table 104. Medtronic Recent Developments/Updates

Table 105. InControl Medical Company Information

Table 106. InControl Medical Description and Business Overview

Table 107. InControl Medical Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. InControl Medical Female Urinary Incontinence Treatment Device Product

Table 109. InControl Medical Recent Developments/Updates

Table 110. Atlantic Therapeutics Group Company Information

Table 111. Atlantic Therapeutics Group Description and Business Overview

Table 112. Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Atlantic Therapeutics Group Female Urinary Incontinence Treatment Device Product

Table 114. Atlantic Therapeutics Group Recent Developments/Updates

Table 115. Axonics Modulation Technologies Company Information

Table 116. Axonics Modulation Technologies Description and Business Overview

Table 117. Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Axonics Modulation Technologies Female Urinary Incontinence Treatment Device Product

Table 119. Axonics Modulation Technologies Recent Developments/Updates

Table 120. Laborie Company Information

Table 121. Laborie Description and Business Overview

Table 122. Laborie Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Laborie Female Urinary Incontinence Treatment Device Product

Table 124. Laborie Recent Developments/Updates

Table 125. Micron Medical Company Information

Table 126. Micron Medical Description and Business Overview

Table 127. Micron Medical Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Micron Medical Female Urinary Incontinence Treatment Device Product

Table 129. Micron Medical Recent Developments/Updates

Table 130. American Medical Solutions Company Information

Table 131. American Medical Solutions Description and Business Overview

Table 132. American Medical Solutions Female Urinary Incontinence Treatment Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. American Medical Solutions Female Urinary Incontinence Treatment Device Product

Table 134. American Medical Solutions Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Female Urinary Incontinence Treatment Device Distributors List

Table 138. Female Urinary Incontinence Treatment Device Customers List

Table 139. Female Urinary Incontinence Treatment Device Market Trends

Table 140. Female Urinary Incontinence Treatment Device Market Drivers

Table 141. Female Urinary Incontinence Treatment Device Market Challenges

Table 142. Female Urinary Incontinence Treatment Device Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Female Urinary Incontinence Treatment Device

Figure 2. Global Female Urinary Incontinence Treatment Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Female Urinary Incontinence Treatment Device Market Share by Type: 2024 & 2031

Figure 4. Urethral Devices Product Picture

Figure 5. Internal Vaginal Devices Product Picture

Figure 6. Global Female Urinary Incontinence Treatment Device Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Female Urinary Incontinence Treatment Device Market Share by Application: 2024 & 2031

Figure 8. Hospitals

Figure 9. Specialty Clinics

Figure 10. Ambulatory Surgical Centers

Figure 11. Others

Figure 12. Global Female Urinary Incontinence Treatment Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Female Urinary Incontinence Treatment Device Market Size (2020-2031) & (US$ Million)

Figure 14. Global Female Urinary Incontinence Treatment Device Sales (2020-2031) & (K Units)

Figure 15. Global Female Urinary Incontinence Treatment Device Average Price (US$/Unit) & (2020-2031)

Figure 16. Female Urinary Incontinence Treatment Device Report Years Considered

Figure 17. Female Urinary Incontinence Treatment Device Sales Share by Manufacturers in 2024

Figure 18. Global Female Urinary Incontinence Treatment Device Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Female Urinary Incontinence Treatment Device Players: Market Share by Revenue in Female Urinary Incontinence Treatment Device in 2024

Figure 20. Female Urinary Incontinence Treatment Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Female Urinary Incontinence Treatment Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Female Urinary Incontinence Treatment Device Sales Market Share by Country (2020-2031)

Figure 23. North America Female Urinary Incontinence Treatment Device Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Female Urinary Incontinence Treatment Device Sales Market Share by Country (2020-2031)

Figure 27. Europe Female Urinary Incontinence Treatment Device Revenue Market Share by Country (2020-2031)

Figure 28. Germany Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Female Urinary Incontinence Treatment Device Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Female Urinary Incontinence Treatment Device Revenue Market Share by Region (2020-2031)

Figure 35. China Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Female Urinary Incontinence Treatment Device Sales Market Share by Country (2020-2031)

Figure 46. Latin America Female Urinary Incontinence Treatment Device Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Female Urinary Incontinence Treatment Device Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Female Urinary Incontinence Treatment Device Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Female Urinary Incontinence Treatment Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Female Urinary Incontinence Treatment Device by Type (2020-2031)

Figure 56. Global Revenue Market Share of Female Urinary Incontinence Treatment Device by Type (2020-2031)

Figure 57. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Female Urinary Incontinence Treatment Device by Application (2020-2031)

Figure 59. Global Revenue Market Share of Female Urinary Incontinence Treatment Device by Application (2020-2031)

Figure 60. Global Female Urinary Incontinence Treatment Device Price (US$/Unit) by Application (2020-2031)

Figure 61. Female Urinary Incontinence Treatment Device Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Female Urinary Incontinence Treatment Device in 2025? zhanKai

The global market size of Female Urinary Incontinence Treatment Device in 2025 was 1130 Million USD.

Which region is expected to have the highest market share? shouQi

What was the global market size of Female Urinary Incontinence Treatment Device in 2031? shouQi

Which companies rank high in the global Female Urinary Incontinence Treatment Device market? shouQi

What is the annual compound growth rate of the global Female Urinary Incontinence Treatment Device market size from 2025 to 2031? shouQi

Related Reports

Female Urinary Incontinence Treatment Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1130 million in 2025 and is projected to reach US$ 1803 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 143
USD 3950.00
(Single User License)
Global Female Urinary Incontinence Treatment Device Market Research Report 2026
The global Female Urinary Incontinence Treatment Device market was valued at US$ 1130 million in 2025 and is anticipated to reach US$ 1803 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 122
USD 2900.00
(Single User License)
Global Female Urinary Incontinence Treatment Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Female Urinary Incontinence Treatment Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 96
USD 4250.00
(Single User License)
Global Female Urinary Incontinence Treatment Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Female Urinary Incontinence Treatment Device market is projected to grow from US$ 1063 million in 2024 to US$ 1696 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 162
USD 4900.00
(Single User License)
Female Urinary Incontinence Treatment Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 126
USD 3950.00
(Single User License)
Global Female Urinary Incontinence Treatment Device Market Insights, Forecast to 2030
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published Date: 2024-04-12
Pages: 109
USD 4900.00
(Single User License)
Global Female Urinary Incontinence Treatment Device Market Research Report 2024
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published Date: 2024-01-17
Pages: 91
USD 2900.00
(Single User License)
Female Urinary Incontinence Treatment Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published Date: 2024-01-10
Pages: 116
USD 3950.00
(Single User License)

Female Urinary Incontinence Treatment Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1130 million in 2025 and is projected to reach US$ 1803 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 143
USD 3950.00 (Single User License)
Global Female Urinary Incontinence Treatment Device Market Research Report 2026
The global Female Urinary Incontinence Treatment Device market was valued at US$ 1130 million in 2025 and is anticipated to reach US$ 1803 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 122
USD 2900.00 (Single User License)
Global Female Urinary Incontinence Treatment Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Female Urinary Incontinence Treatment Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 96
USD 4250.00 (Single User License)
Global Female Urinary Incontinence Treatment Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Female Urinary Incontinence Treatment Device market is projected to grow from US$ 1063 million in 2024 to US$ 1696 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 162
USD 4900.00 (Single User License)
Female Urinary Incontinence Treatment Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Female Urinary Incontinence Treatment Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1696 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 126
USD 3950.00 (Single User License)
Global Female Urinary Incontinence Treatment Device Market Insights, Forecast to 2030
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published: 2024-04-12
Pages: 109
USD 4900.00 (Single User License)
Global Female Urinary Incontinence Treatment Device Market Research Report 2024
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published: 2024-01-17
Pages: 91
USD 2900.00 (Single User License)
Female Urinary Incontinence Treatment Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.
Published: 2024-01-10
Pages: 116
USD 3950.00 (Single User License)